# Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate

> **NCT01341379** · PHASE2 · WITHDRAWN · sponsor: **Children's Hospital of Philadelphia**

## Conditions studied

- Urea Cycle Disorders, Inborn
- Inborn Errors of Metabolism
- Propionic Acidemia
- Methylmalonic Acidemia
- Carbamyl Phosphate Synthetase Deficiency

## Interventions

- **DRUG:** N-carbamylglutamate

## Key facts

- **NCT ID:** NCT01341379
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-12
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2014-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01341379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01341379, "Increasing Ureagenesis in Inborn Errors of Metabolism With N-Carbamylglutamate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01341379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*